EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Net Current Assets History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹15 Cr | ₹7.98 Cr | ₹-11 Cr | ₹-5.10 Cr | ₹5.32 Cr |
What is the latest Net Current Assets ratio of EVEREST ORGANICS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹15 Cr |
| Mar2025 | ₹7.98 Cr |
| Mar2024 | ₹-11 Cr |
| Mar2023 | ₹-5.10 Cr |
| Mar2022 | ₹5.32 Cr |
How is Net Current Assets of EVEREST ORGANICS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹15 Cr | 90.95 | |
| Mar2025 | ₹7.98 Cr | Positive | |
| Mar2024 | ₹-11 Cr | Negative | |
| Mar2023 | ₹-5.10 Cr | Negative | |
| Mar2022 | ₹5.32 Cr | - | |
Compare Net Current Assets of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹251.3 Cr | 6.7% | 3.8% | -39% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 6.7% |
3.8% |
-39% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses